Hepatitis C Management in Special Populations

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 8/17/18 (What's New)

Summary

  • Multiple international guidelines agree that HCV treatment should be considered in the HCV/HIV-coinfected person
    • Immediate treatment should be prioritized in HCV/HIV-coinfected patients due to increased risk of hepatic complications (Management Guidelines)[AASLD-IDSA HCV]
    • Concurrent treatment of both HIV and HCV is feasible, efficacious, and safe, but may be complicated by drug interactions

Action required

Keywords: Hepatitis C, Hepatitis C-Special Populations

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.